EdgarBen-JosefMD

Radiation Oncology • Philadelphia, PA

Professor, Radiation Oncology, Perelman School of Medicine

Join to view full profile

Dr. Ben-Josef is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ben-Josef's full profile

Already have an account?

Office
3400 Civic Center Blvd
Concourse Level
Philadelphia, PA 19104
Phone+1 215-662-2428

Education & Training

Detroit Medical Center/Wayne State UniversityResidency, Radiation Oncology, 1990 - 1993
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1986

Certifications & Licensure

PA State Medical License 2011 - 2024
MI State Medical License 1992 - 2014
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Start of enrollment: 2008 Dec 01
Completed
Phase 2
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma Start of enrollment: 2009 Aug 01
Completed
Not Applicable
TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients Start of enrollment: 2013 Jul 01
Active, not recruiting
Not Applicable
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery Start of enrollment: 2013 Aug 01
Terminated
Phase 2
A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas Start of enrollment: 2013 Jul 01
Completed
Not Applicable
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer Start of enrollment: 2014 Jul 01
Recruiting
Phase 1
A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION Start of enrollment: 2017 Apr 05
Completed
Join now to see all

Publications & Presentations

PubMed

Clinical outcomes and risk stratification in unresectable biliary tract cancers undergoing radiation therapy.
Uri Amit, Misra Shagun, John P Plastaras, James M Metz, Thomas B Karasic
Radiation Oncology. 2024-08-01
1 citations
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer.
Uri Amit, Ugur Uslu, Ioannis I Verginadis, Michele M Kim, Seyyedeh Azar Oliaei Motlagh
Proceedings of the National Academy of Sciences of the United States of America. 2024-07-30
1 citations
SMAD4 loss predicts worse overall and distant metastasis-free survival in patients with resected pancreatic adenocarcinoma.
Emily J Anstadt, Ruben Carmona, Eva Berlin, Nikhil Yegya-Raman, Sriram Venigalla
Cancer. 2024-02-01

Press Mentions

Proton Beam RT Doubled OS in Unresectable Liver CancerNovember 5th, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member